News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provectus Pharmaceuticals Inc. Appoints Dr. Joseph M. Chalil To Strategic Advisory Board


3/19/2014 7:23:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT), http://www.pvct.com, a development-stage oncology and dermatology biopharmaceutical company, announced that it has appointed Dr. Joseph M. Chalil, MD, MBA, FACHE, to its Strategic Advisory Board.

Dr. Chalil is Associate Director, Health Science Executives of Boehringer Ingelheim, the world’s largest privately held pharmaceutical company. Headquartered in Ingelheim, Germany, the company operates globally in more than 50 countries. In 2012, Boehringer Ingelheim achieved net sales of 19.1 billion (USD); R&D expenditure in the business area of prescription medicines reached a quarter of its net sales.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES